Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: A preliminary report

  • 21 Accesses

  • 7 Citations

Summary

Forty-four adult patients under 60 years of age with acute nonlymphoblastic leukemia were randomized for induction treatment with one of the following three regimens: R 1 = courses of daunorubicin on day 1+ARA-C on days 1–5; R 2 = courses of daunorubicin on days 1 and 2+ARA-C on days 4–8; R 3 = courses of daunorubicin-DNA complex on days 1–2+ ARA-C on days 4–8.

Out of 14 patients, 9 went into remission on R 1, 6 out of 14 on R 2, and 8 out of 16 on R 3. The preliminary results suggest that daunorubicin-DNA complex has the same efficacy for inducing remission as daunorubicin alone, if the same time intervals and dosages are used.

This is a preview of subscription content, log in to check access.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Bernard, J., Paul, R., Boiron, M., Jacquillat, C., Maral, R.: Rubidomycin. In: Recent results in cancer research, p. 29. Berlin, Heidelberg, New York: Springer 1969

  2. Cornu, G., Michaux, J. L., Sokal, G., Trouet, G.: Daunorubicin-DNA: Further clinical trials in acute non-lymphoblastic leukemia. Eur. J. Cancer 10, 695 (1974)

  3. Crowther, D., Bateman, C. J. T., Vartan, C. P., Whitehouse, J. M. A., Nalpas, J. S., Hamilton Fairly, G., Scott, R.: Combination chemotherapy using l-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukemia. Br. Med. J. 1970 IV, 513

  4. Ferrant, A., Hulhoven, R., Bosly, A., Cornu, G., Michaux, J. L., Sokal, G.: Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute non-lymphoblastic leukemia and bronchogenic carcinoma. Cancer Chemother. Pharmacol. 2, 67–71 (1979)

  5. Gahrton, G. et al.: Maintenance treatment of acute leukemia in adults (in Swedish). Fin. Laekaresaellsk. Handl. 120, 268 (1976)

  6. Hoff, D. D. von, Rozencweig, M., Layard, M., Slavnik, M., Muggia, F. M.: Daunorubicin induced cardiotoxicity in children and adults. A review of 110 cases. Am. J. Med. 62, 200 (1977)

  7. Jacquillat, C., Boiron, M., Weil, M., Tanzer, J., Najean, Y., Bernard, J.: Rubidomycin, a new agent active in the treatment of acute leukemia. Lancet 1966 II, 27

  8. Langslet, A., Øye, I., Lie, S. O.: Decreased cardiac toxicity of adriamycin and daunorubicin when bound to DNA. Acta Pharmacol. Toxicol. (Kbh.) 35, 379 (1974)

  9. Lefrak, E. A., Pitha, J., Rosenheim, S., Gottlieb, J. A.: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32, 302 (1973)

  10. Lindemalm, C. S.-N. et al.: Adjuvant immunotherapy in acute non-lymphocytic leukemia. Cancer Immunol. Immunother. 4, 179–183 (1978)

  11. Michaux, J. L., Cornu, G., Sokal, G., Trouet, A.: Preliminary clinical trials with the adriamycin DNA complex in human leukemias and non-Hodgkin lymphomas. Adriamycin review. Staquet, M. et. al. (eds.), Part 3, p. 216. Ghent, Belgium: European Press Medikon 1975

  12. Reizenstein, P. et al.: Effect of immunotherapy on survival and remission duration in acute non-lymphatic leukemia. In: Immunotherapy of cancer: Present status of trials in man. Prog. Cancer Res. Ther. 6, 329 (1977)

  13. Sokal, G., Trouet, A., Michaux, J., Cornu, G.: DNA-daunorubicin complex: Preliminary trials in human leukemia. Eur. J. Cancer 9, 391 (1973)

  14. Trouet, A., Deprez-de Campeneere, D., Duve, C. de: Chemotherapy through lysosomes with DNA-daunorubicin complex. Nature [New Biol.] 239, 110 (1972)

  15. Trouet, A., Deprez-de Campeneere, D., Smedt-Malengreaux, M. de, Atassi, G.: Experimental leucemia chemotherapy with a ‘lysosomotropic’ adriamycin-DNA complex. Eur. J. Cancer 10, 405 (1974)

  16. Trouet, A., Depre-de Campeneere, D., Zeneberg, A., Hullhoven, R.: Lysosomotropic cancer chemotherapy with adriamycin-DNA. In: Adriamycin review. Staquet, M. et al. (eds.), Part 1, p. 62. Ghent, Belgium: European Press Medikon 1975

  17. Udén, A.-M. et al.: l-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia. Scand. J. Haematol. 15, 72 (1975)

  18. Weil, M., et al.: Daunorubicin in the therapy of acute granulocytic leukemia. Cancer Res. 33, 921 (1973)

Download references

Author information

Correspondence to G. Gahrton.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gahrton, G., Björkholm, M., Brenning, G. et al. Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: A preliminary report. Cancer Chemother. Pharmacol. 2, 73–76 (1979). https://doi.org/10.1007/BF00253109

Download citation

Keywords

  • Leukemia
  • Cancer Research
  • Adult Patient
  • Preliminary Report
  • Daunorubicin